Profil
Torsten Neuefeind is the founder of Proteros biostructures GmbH, serving as Chief Executive Officer & Director since 1998.
Former positions include Principal at Bayer AG and Principal at Max-Planck-Institute for Molecular Genetics.
Education includes a doctorate from the University of Freiburg and an undergraduate degree from Philipps University of Marburg.
Aktive Positionen von Torsten Neuefeind
| Unternehmen | Position | Beginn |
|---|---|---|
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Gründer | 05.02.2010 |
Ehemalige bekannte Positionen von Torsten Neuefeind
| Unternehmen | Position | Ende |
|---|---|---|
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| BAYER AG | Corporate Officer/Principal | - |
Ausbildung von Torsten Neuefeind
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Health Services |
















